Thrivent Financial for Lutherans
CABA icon

Thrivent Financial for Lutherans’s Cabaletta Bio CABA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-95,327
Closed -$145K – 2399
2025
Q2 		$145K Hold
95,327
– – ﹤0.01% 2407
2025
Q1 		$132K Hold
95,327
– – ﹤0.01% 2340
2024
Q4 		$216K Buy
+95,327
New +$335K ﹤0.01% 2497

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Thrivent Financial for Lutherans's CABA Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 95,327 shares — an estimated $145K sold.

Thrivent Financial for Lutherans first reported a position in CABA in Q4 2024 and held it in 3 quarters. The position peaked at $216K in Q4 2024. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 95,327 Cabaletta Bio shares in Q3 2025, an estimated $145K.
  • Thrivent Financial for Lutherans first reported a position in Cabaletta Bio in Q4 2024 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Cabaletta Bio position peaked at $216K in Q4 2024.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.